These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 25253684

  • 21. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P, Sever J, Weizman A.
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [Abstract] [Full Text] [Related]

  • 22. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H, Whitwell S, Riemer K, Sharma K, Sharma SP, Wood N, Kelly J, Golaszewski A, Kennedy J, Rodney L, West N, Walwyn R, Jichi F.
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [Abstract] [Full Text] [Related]

  • 23. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 24. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Jun; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 25. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.
    Emilsson M, Gustafsson PA, Öhnström G, Marteinsdottir I.
    Eur Child Adolesc Psychiatry; 2017 May; 26(5):559-571. PubMed ID: 27848023
    [Abstract] [Full Text] [Related]

  • 26. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P, Maipang P.
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [Abstract] [Full Text] [Related]

  • 27. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F, Yilmaz I, Yulaf Y, Gokce S, Sabuncuoglu O.
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [Abstract] [Full Text] [Related]

  • 28. Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD.
    Pelham WE, Gnagy EM, Sibley MH, Kipp HL, Smith BH, Evans SW, Bukstein O.
    J Atten Disord; 2017 Jan; 21(2):129-136. PubMed ID: 23893533
    [Abstract] [Full Text] [Related]

  • 29. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY, Hwang JW, Kwak YS, Joung YS, Lee S, Kim B, Sohn SH, Chung US, Yang J, Hong M, Bahn GH, Choi HY, Oh IH, Lee YJ.
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [Abstract] [Full Text] [Related]

  • 30. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
    Niederkirchner K, Slawik L, Wermelskirchen D, Rettig K, Schäuble B.
    Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
    [Abstract] [Full Text] [Related]

  • 31. An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Groenman AP, Schweren LJ, Dietrich A, Hoekstra PJ.
    Expert Opin Drug Saf; 2017 Apr; 16(4):455-464. PubMed ID: 28277842
    [Abstract] [Full Text] [Related]

  • 32. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, Squires L.
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [Abstract] [Full Text] [Related]

  • 33. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.
    Pearson DA, Santos CW, Roache JD, Casat CD, Loveland KA, Lachar D, Lane DM, Faria LP, Cleveland LA.
    J Am Acad Child Adolesc Psychiatry; 2003 Feb; 42(2):209-16. PubMed ID: 12544181
    [Abstract] [Full Text] [Related]

  • 34. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.
    Findling RL, Short EJ, Manos MJ.
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290
    [Abstract] [Full Text] [Related]

  • 35. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract] [Full Text] [Related]

  • 36. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Davis M, Mikami AY, Singh H, Merkel RL, Burket R.
    J Clin Psychopharmacol; 2012 Apr 23; 32(2):225-30. PubMed ID: 22367664
    [Abstract] [Full Text] [Related]

  • 37. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun 23; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 38. Review of medication adherence in children and adults with ADHD.
    Adler LD, Nierenberg AA.
    Postgrad Med; 2010 Jan 23; 122(1):184-91. PubMed ID: 20107302
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S.
    J Clin Pharm Ther; 2004 Apr 23; 29(2):139-44. PubMed ID: 15068402
    [Abstract] [Full Text] [Related]

  • 40. Caught in the eye of the storm: a qualitative study of views and experiences of planned drug holidays from methylphenidate in child and adolescent ADHD treatment.
    Ibrahim K, Vogt C, Donyai P.
    Child Adolesc Ment Health; 2016 Nov 23; 21(4):192-200. PubMed ID: 32680336
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.